Disease Epidemiology / Clinical Course / Other

((C-016)) (C-016) Characterizing dupilumab-naïve patients with bullous pemphigoid using US administrative claims data

((C-017)) (C-017) Changes in the incidence of adverse events of special interest after diagnosis of COVID-19 between November 2020 and January 2024

((C-018)) (C-018) Comparing Patterns of Hepatitis C Events by Treatment in Commercially-Insured Individuals with Opioid Use Disorder

((C-019)) (C-019) Rate of Bowel Resection Surgeries among Children with Inflammatory Bowel Disease

((C-020)) (C-020) Paradox Association between Body Mass Index with Occurrence and Fatality of Venous Thromboembolism in Hospitalized Patients: A National Hospital-Based Analysis

((C-021)) (C-021) Age-Specific Associations and Attributable Burden of Risk Factors for All-cause and Cause-specific Mortality in Patients with Chronic Kidney Disease

((C-022)) (C-022) Exploring the prognostic importance of serum phosphate levels and hyperphosphatemia on mortality and composite endpoints in non-dialysis CKD patients: a real-world evidence study

((C-023)) (C-023) A Profile Study of Characteristics and Treatment of Preterm and Term Births in the United Sates: An Analysis of the CDC WONDER Database, 2016-2023

((C-024)) (C-024) Plasma Vitamin D Status and Its Association with Biochemical, Clinical and Humanistic Outcomes in Diabetic Foot Infection Patients: A Prospective Observational Study in a Tertiary Healthcare Facility

((C-025)) (C-025) The burden of physical and psychological symptoms among patients with asthma in Jordan

((C-026)) (C-026) Atopic eczema and subsequent hospital-recorded diagnoses: an outcome-wide study

((C-027)) (C-027) Considerations for estimating prevalence and incidence based on systematic literature review: an example in geographic atrophy

((C-028)) (C-028) A Retrospective, Non-interventional Cohort Study of Visual Acuity Changes in Patients with Interstitial Cystitis Receiving Pentosan Polysulfate Sodium

((C-029)) (C-029) Estimating the Effect of Hepatitis C on End-of-Treatment Outcomes Under Adequate Adherence to Strong Multidrug- and Rifampicin Resistant Tuberculosis Regimens

((C-030)) (C-030) Obesity and obesity-related metabolic factors and incident diverticulitis risk in a US cohort of women

((C-031)) (C-031) Understanding the age-specific risk factors for COVID-19: A machine learning approach

((C-032)) (C-032) Lyme Disease Reinfections: An analysis of US Health Insurance Claims Data

((C-033)) (C-033) Prevalence and Incidence of Cutaneous Lupus Erythematosus: A Systematic Literature Review

((C-034)) (C-034) Psychological effects of preterm birth on mothers: A scoping review

((C-035)) (C-035) Does COVID-19 relate to adverse maternal outcomes? Risk of cesarean section and preterm birth among Japanese women with COVID-19 during pregnancy.

((C-036)) (C-036) Incidence Rates of Suicidality Related Events in Patients with Specific Chronic Skin Conditions

((C-037)) (C-037) Hospitalization Risk in Persons with and without HIV Initiating Metformin for Type 2 Diabetes

((C-038)) (C-038) Association of Hepatitis B Surface Antigen Loss (HBsAg) with Clinical Outcomes Among Patients with Chronic Hepatitis B Virus (HBV) Infection: A Retrospective Cohort Study in the United States (US)

((C-039)) (C-039) DARWIN EU® - Paracetamol overdose: a descriptive analysis of incidence rates and patient characteristics

((C-040)) (C-040) Levetiracetam and the Risk of Thrombocytopenia: Active-comparator restricted disproportionality analysis

((C-041)) (C-041) Active Surveillance of Mosquito-borne Diseases in the United States

((C-042)) (C-042) Active Surveillance of Foodborne Diseases in the United States

((C-043)) (C-043) Lung Function Assessment in Patients with Persistent Asthma: Impact of Disease Severity and Acute Exacerbation Status

((C-044)) (C-044) Accelerated Biological Aging and Postoperative Adverse Renal Events: A Multicenter Cohort Study

((C-045)) (C-045) Acute All-cause hospitalization following medically-attended acute gastroenteritis (AGE) and norovirus AGE among patients with underlying chronic conditions in the United States, 2022–2024

((C-046)) (C-046) Epidemiology and Risk Factors for Antimicrobial Resistance in ICU Patients with Acinetobacter baumannii Infections: A Retrospective Study in an Indian Hospital

((C-047)) (C-047) DARWIN EU® - Characterisation and survival of elderly with recurrent falls in Europe

((C-048)) (C-048) Global Assessment of the Diagnosed Prevalence of Psoriasis and Plaque Psoriasis

((C-049)) (C-049) Epidemiology of intraoperative and postoperative complications in patients undergoing left-sided colorectal surgery for benign or malignant colorectal disease in England

((C-050)) (C-050) Real-world Observational Study of Patients with Potential Non-Idiopathic Progressive Pulmonary Fibrosis and Risk Factors of Progression

((C-051)) (C-051) Global Assessment of the Diagnosed Prevalence of Psoriatic Arthritis

((C-052)) (C-052) Using Real-World Data Landscaping to Address Gaps in Patient Insights: A Real-Use Case Study in Chronic Wound Care

((C-053)) (C-053) Opioid Tapering and Functional Status among Older Adults on Long-Term Opioid Therapy Receiving Home Health Care

((C-054)) (C-054) Predictors of Home Healthcare Admission among Older Adults on Long-Term Opioid Therapy

((C-055)) (C-055) Herpes Zoster Incidence Rates by Age for United States adults with Comorbid Conditions

((C-056)) (C-056) Incidence and Severity of Human Metapneumovirus Infection in Adult Populations: A Literature Review

((C-057)) (C-057) Impact of cumulative non-pharmacological interventions on the incidence of acute and chronic conditions before and after the COVID-19 pandemic in Europe and the United States

((C-058)) (C-058) Obesity and Ventilator-Associated Pneumonia: Results from Electronic Health Record

((C-059)) (C-059) PRESIENTE: A Community-Based Prospective Cohort Study of Respiratory and Gastrointestinal Illness in Peru

((C-060)) (C-060) Characterization of Adult Patients with Cystic Fibrosis in the TriNetX Linked EHR + Claims Network

((C-061)) (C-061) Development and Validation of an N-gram Model for Differentiating between Melena and Hematochezia Using Unstructured Clinical Notes

((C-062)) (C-062) Utilization of hormonal contraceptives during the postpartum period in the FDA Sentinel System